RO85679B1 - Smoking control device - Google Patents
Smoking control deviceInfo
- Publication number
- RO85679B1 RO85679B1 RO109332A RO10933282A RO85679B1 RO 85679 B1 RO85679 B1 RO 85679B1 RO 109332 A RO109332 A RO 109332A RO 10933282 A RO10933282 A RO 10933282A RO 85679 B1 RO85679 B1 RO 85679B1
- Authority
- RO
- Romania
- Prior art keywords
- control device
- acid
- vitamin
- smoking
- smoking control
- Prior art date
Links
- 230000000391 smoking effect Effects 0.000 title abstract 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 235000001258 Cinchona calisaya Nutrition 0.000 abstract 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 241000241413 Propolis Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 235000013921 calcium diglutamate Nutrition 0.000 abstract 1
- UMVAYAXXQSFULN-QHTZZOMLSA-L calcium;(2s)-2-aminopentanedioate;hydron Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O UMVAYAXXQSFULN-QHTZZOMLSA-L 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 1
- 230000001143 conditioned effect Effects 0.000 abstract 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
- 229910000397 disodium phosphate Inorganic materials 0.000 abstract 1
- 235000019800 disodium phosphate Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004919 procaine Drugs 0.000 abstract 1
- 229940069949 propolis Drugs 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960000948 quinine Drugs 0.000 abstract 1
- 239000001488 sodium phosphate Substances 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inventia se refera la un preparat pentru combaterea fumatului care este constituit din 3...8g chinina, 15...30 acid ascorbic, 5...15g vitamina B6, 5...15g vitamina PP, 5...15g acid D-aspartic, 1...3g acid alfa-cetoglutaric, 3...8g fosfat monopotasic, 3...8g fosfat disodic, 15...25g glutamat de calciu, 0...75g lecitina, 0...8g procaina, 150...250g extract standardizat de propolis, conditionat sub forma de comprimate sau capsule cu adaos de excipienti în sine cunoscuti.The invention relates to a preparation for combating smoking which consists of 3 ... 8g quinine, 15 ... 30 ascorbic acid, 5 ... 15g vitamin B6, 5 ... 15g vitamin PP, 5 ... 15g acid D-aspartate, 1 ... 3g alpha-ketoglutaric acid, 3 ... 8g monopotasic phosphate, 3 ... 8g disodium phosphate, 15 ... 25g calcium glutamate, 0 ... 75g lecithin, 0 ... 8 g procaine, 150 ... 250 g standardized propolis extract, conditioned as tablets or capsules with added excipients in their own right.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO109332A RO85679B1 (en) | 1982-12-16 | 1982-12-16 | Smoking control device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO109332A RO85679B1 (en) | 1982-12-16 | 1982-12-16 | Smoking control device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO85679A2 RO85679A2 (en) | 1984-10-31 |
| RO85679B1 true RO85679B1 (en) | 1984-11-30 |
Family
ID=20112364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO109332A RO85679B1 (en) | 1982-12-16 | 1982-12-16 | Smoking control device |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO85679B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7851006B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
| US7851005B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7955630B2 (en) | 2004-09-30 | 2011-06-07 | Kraft Foods Global Brands Llc | Thermally stable, high tensile strength encapsulated actives |
| US9198448B2 (en) | 2005-02-07 | 2015-12-01 | Intercontinental Great Brands Llc | Stable tooth whitening gum with reactive ingredients |
| WO2006127934A2 (en) * | 2005-05-23 | 2006-11-30 | Cadbury Adams Usa, Llc | Taste potentiator compositions and edible confectionery and chewing gum products containing same |
| IT1393649B1 (en) * | 2008-07-24 | 2012-05-08 | Forem Pharma S R L | PREPARED FOR THE CORRECT DEVELOPMENT OF AN INDIVIDUAL. |
-
1982
- 1982-12-16 RO RO109332A patent/RO85679B1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7851006B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
| US7851005B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
Also Published As
| Publication number | Publication date |
|---|---|
| RO85679A2 (en) | 1984-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3376387D1 (en) | The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis | |
| MX6446E (en) | PROCEDURE FOR THE PREPARATION OF GERMICIDED IODINE COMPOSITIONS THAT HAVE INCREASED STABILITY | |
| ES8600060A1 (en) | Galenic form for the administration by inhalation of calcium antagonists. | |
| IL86951A0 (en) | Methylene phosphonoalkylphosphinates and pharmaceutical compositions containing them | |
| IT8047948A0 (en) | WHICH CONTAIN THEM AS WELL AS ALPHA-ALKYLAMINOPROPIOUS COMPOUNDS FOR THEIR PREPARATION NONICES AND PHARMACEUTICAL COMPOSITIONS | |
| AR248140A1 (en) | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors | |
| DK0785769T3 (en) | Therapeutic vitamin-calcium combination in the form of a galenic unit dose tablet, method for preparing this product | |
| IT8341572A0 (en) | SYSTEM FOR THE SURVEILLANCE OF METAL-TO-METAL CONTACT IN ROTATING MACHINERY. | |
| ES431614A1 (en) | A PROCEDURE FOR THE PREPARATION OF CARBOXIAL-CHILIC ESTERS OF N-PHOSPHONOMETHYLGLYCIN. | |
| DE3171928D1 (en) | Pharmaceutical formulation and its preparation | |
| IT7826008A0 (en) | ADDUCTS OF VITAMIN COMPOUNDS OF THE K TYPE AND STABILIZING VITAMINS, THEIR PREPARATION AND STABILIZED ADDUCTS SO OBTAINED. | |
| IT9019324A1 (en) | BILOBALIDE DERIVATIVES, THEIR USES AND FORMULATIONS THAT CONTAIN THEM | |
| IL63741A (en) | Preparation of the calcium salt of alpha-hydroxy-ypsilon-methyl-mercaptobutyric acid | |
| GR3004440T3 (en) | ||
| FR2432520A1 (en) | NOVEL IMIDAZOQUINOXALINS AND THEIR SALTS, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| SE8200252L (en) | PHARMACEUTICAL COMPOSITION | |
| IT1079788B (en) | RED PHOSPHORUS STABILIZED AS WELL AS PROCEDURE FOR ITS PRODUCTION | |
| ES515331A0 (en) | A PROCEDURE FOR THE PREPARATION OF TETRAZOLE DERIVATIVES. | |
| ES500869A0 (en) | A PROCEDURE FOR THE PREPARATION OF A STABLE CONCEN-TRADA SOLUTION OF CISPLATIN | |
| ATE41740T1 (en) | PROCEDURES FOR RETARDATION OF VITAMINS C AND E. | |
| IT8619787A0 (en) | COMPOUNDS CONTAINING BIOAVAILABLE IRON, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| DK0497177T3 (en) | Vitamin containing formulations and preparation thereof | |
| IL59295A0 (en) | Dehydropeptide compounds,their production and pharmaceutical compositions containing them | |
| IL61985A0 (en) | Phosphinic and phosphonic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
| CA2122908A1 (en) | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |